Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma

BACKGROUND: TP53 is frequently altered in esophageal squamous cell carcinoma (ESCC). However, the landscape of TP53 mutation and its effects on patients remain controversial. METHODS: Somatic mutations of TP53 in 161 patients with resectable ESCC were identified by next-generation sequencing (NGS) a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Transl Med
Prif Awduron: Huang, Minran, Jin, Jiaoyue, Zhang, Fanrong, Wu, Yingxue, Xu, Chenyang, Ying, Lisha, Su, Dan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7186752/
https://ncbi.nlm.nih.gov/pubmed/32355760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.142
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg